erlotinib

⇄

mitogen-activated protein kinase kinase 1 ; Homo sapiens







1 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31827134 MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma. 2019 Dec 11 2